Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Netherlands: Antiretroviral therapy coverage
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
26.5%
in 2024
Netherlands
89.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
22nd
Netherlands rank
21st
Antiretroviral therapy coverage over time
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Netherlands
How they compare
Netherlands currently reports 89.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 62.5%.
That makes Netherlands's figure about 3.4 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
Across all 24 years both countries report, Netherlands has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd and Netherlands ranks 21st of 23 groups.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 53.5% | 50.1% | Netherlands |
| 2010s | 12.8% | 77.2% | 64.4% | Netherlands |
| 2020s | 22.3% | 87.8% | 65.5% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Netherlands?
- Netherlands, at 89.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2023.
- What is the difference in antiretroviral therapy coverage between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Netherlands?
- 62.5%, with Netherlands ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Netherlands?
- 24 years are reported by both, from 2000 to 2023.
- How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Netherlands rank globally for antiretroviral therapy coverage?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd and Netherlands ranks 21st of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.